Original Research

Published on 11 Mar 2024

Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19

in Cytokines and Soluble Mediators in Immunity

Daisuke Kasugai
Taku Tanaka
Takako Suzuki
Yoshinori Ito
Kazuki Nishida
Masayuki Ozaki
Takeo Kutsuna
Toshiki Yokoyama
Hitoshi Kaneko
Ryo Ogata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1337070

1,682 views

Mini Review

Published on 08 Mar 2024

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation

in Cytokines and Soluble Mediators in Immunity

Marie Bielenberg
Roberta Kurelic
Stefan Frantz
Viacheslav O. Nikolaev

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365484

2,695 views
1 citation

Original Research

Published on 08 Mar 2024

Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity

in Cytokines and Soluble Mediators in Immunity

Eunhye Yeo
Joonho Shim
Se Jin Oh
YoungHwan Choi
Hyungrye Noh
Heeyeon Kim
Ji-Hye Park
Kyeong-Tae Lee
Seok-Hyung Kim
Dongyoun Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1339336

3,762 views

Original Research

Published on 07 Mar 2024

Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro

in Cytokines and Soluble Mediators in Immunity

Hesham M. Shehata
Pranay Dogra
Sarah Gierke
Patrick Holder
Shomyseh Sanjabi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1341804

2,404 views

Original Research

Published on 06 Mar 2024

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection

in Cytokines and Soluble Mediators in Immunity

Weicong Ren
Zichun Ma
Qiang Li
Rongmei Liu
Liping Ma
Cong Yao
Yuanyuan Shang
Xuxia Zhang
Mengqiu Gao
Shanshan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359555

1,905 views

Editorial

Published on 05 Mar 2024

Editorial: Role of carcinoembryonic antigen-related cell adhesion molecules in pathogen responses, tumorigenicity, and immune modulation

in Cytokines and Soluble Mediators in Immunity

Vishal Khairnar
Vu N. Ngo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388453

981 views

Original Research

Published on 28 Feb 2024

IL-6 signaling drives self-renewal and alternative activation of adipose tissue macrophages

in Cytokines and Soluble Mediators in Immunity

Jan Ackermann
Lilli Arndt
Janine Fröba
Andreas Lindhorst
Markus Glaß
Michaela Kirstein
Constance Hobusch
F. Thomas Wunderlich
Julia Braune
Martin Gericke

Frontiers in Immunology

doi 10.3389/fimmu.2024.1201439

3,060 views
2 citations

Original Research

Published on 28 Feb 2024

IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function

in Cytokines and Soluble Mediators in Immunity

Huixia Zhao
Lili Shang
Yuting Zhang
Zhaojun Liang
Nan Wang
Qian Zhang
Chong Gao
Jing Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1344963

4,573 views
4 citations

Original Research

Published on 23 Feb 2024

Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation

in Cytokines and Soluble Mediators in Immunity

Marta Lombardi
Federica Scaroni
Martina Gabrielli
Stefano Raffaele
Elisabetta Bonfanti
Fabia Filipello
Paola Giussani
Silvia Picciolini
Nicole Kerlero de Rosbo
Antonio Uccelli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1331210

3,467 views
5 citations

Original Research

Published on 22 Feb 2024

Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19

in Cytokines and Soluble Mediators in Immunity

Ancha Baranova
Jing Luo
Li Fu
Guanqun Yao
Fuquan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1352583

2,599 views
4 citations

Original Research

Published on 20 Feb 2024

The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol

in Cytokines and Soluble Mediators in Immunity

José Lentilhas-Graça
Diogo J. Santos
João Afonso
Andreia Monteiro
Andreia G. Pinho
Vera M. Mendes
Marta S. Dias
Eduardo D. Gomes
Rui Lima
Luís S. Fernandes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1354479

4,319 views

Original Research

Published on 15 Feb 2024

Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation

in Cytokines and Soluble Mediators in Immunity

Valerie J. Brock
Niels Christian Lory
Franziska Möckl
Melina Birus
Tobias Stähler
Lena-Marie Woelk
Michelle Jaeckstein
Joerg Heeren
Friedrich Koch-Nolte
Björn Rissiek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1258119

2,316 views
2 citations

Mini Review

Published on 15 Feb 2024

Purinergic enzymes on extracellular vesicles: immune modulation on the go

in Cytokines and Soluble Mediators in Immunity

Riekje Winzer
Du Hanh Nguyen
Felix Schoppmeier
Filippo Cortesi
Nicola Gagliani
Eva Tolosa

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362996

2,359 views
2 citations

Review

Published on 14 Feb 2024

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

in Cytokines and Soluble Mediators in Immunity

Marsha Pellegrino
Valerio Secli
Silvia D’Amico
Lucia Lisa Petrilli
Matteo Caforio
Valentina Folgiero
Nicola Tumino
Paola Vacca
Maria Vinci
Doriana Fruci

Frontiers in Immunology

doi 10.3389/fimmu.2024.1356321

3,136 views
6 citations

Review

Published on 09 Feb 2024

Cytokine gene polymorphisms implicated in the pathogenesis of Plasmodium falciparum infection outcome

in Cytokines and Soluble Mediators in Immunity

Selorm Philip Segbefia
Diana Asema Asandem
Linda Eva Amoah
Kwadwo Asamoah Kusi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1285411

2,218 views
1 citation

Review

Published on 08 Feb 2024

Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE

in Cytokines and Soluble Mediators in Immunity

Christophe Wong
Ivana Stoilova
Florence Gazeau
Jean-Philippe Herbeuval
Thibaut Fourniols

Frontiers in Immunology

doi 10.3389/fimmu.2024.1355845

3,812 views
5 citations

Navigation group

Articles

Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation

Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity

Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection

Editorial: Role of carcinoembryonic antigen-related cell adhesion molecules in pathogen responses, tumorigenicity, and immune modulation

IL-6 signaling drives self-renewal and alternative activation of adipose tissue macrophages

IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function

Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation

Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19

The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol

Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation

Purinergic enzymes on extracellular vesicles: immune modulation on the go

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Cytokine gene polymorphisms implicated in the pathogenesis of Plasmodium falciparum infection outcome

Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE